Alzamend Neuro, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-6.6M | $-6.6M | — | $4.4M |
| FY2023 | $-8.9M | $-8.9M | — | $3.6M |
| FY2024 | $-8.3M | $-8.3M | — | $955.6K |
| FY2025 | $-6.6M | $-6.6M | — | $325.1K |
| FY2026 | $-8.1M | $-8.1M | — | $707.5K |